X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tobramycin (632) 632
humans (455) 455
index medicus (444) 444
pharmacology & pharmacy (311) 311
antibiotics (308) 308
anti-bacterial agents - pharmacology (234) 234
anti-bacterial agents - chemistry (200) 200
tobramycin - pharmacology (195) 195
anti-bacterial agents - administration & dosage (192) 192
male (180) 180
tobramycin - chemistry (177) 177
animals (176) 176
tobramycin - administration & dosage (159) 159
aminoglycosides (158) 158
pseudomonas aeruginosa - drug effects (156) 156
microbiology (153) 153
female (152) 152
gentamicin (145) 145
cystic fibrosis (144) 144
pseudomonas aeruginosa (141) 141
microbial sensitivity tests (140) 140
biochemistry & molecular biology (134) 134
bacteria (116) 116
aminoglycoside antibiotics (114) 114
chemistry, analytical (105) 105
administration, inhalation (97) 97
infections (96) 96
adult (95) 95
anti-bacterial agents - pharmacokinetics (93) 93
pseudomonas-aeruginosa (93) 93
analysis (92) 92
cystic-fibrosis (89) 89
pharmacokinetics (85) 85
resistance (85) 85
infection (83) 83
biofilms - drug effects (81) 81
drug delivery systems (80) 80
biofilms (78) 78
chemistry, multidisciplinary (76) 76
anti-bacterial agents - therapeutic use (75) 75
antibacterial agents (73) 73
pseudomonas infections - drug therapy (73) 73
tobramycin - pharmacokinetics (72) 72
tobramycin - blood (71) 71
in-vitro (70) 70
respiratory system (70) 70
chemistry, medicinal (69) 69
drugs (69) 69
research (66) 66
adolescent (65) 65
tobramycin - metabolism (64) 64
amikacin (63) 63
infectious diseases (63) 63
time factors (63) 63
cystic fibrosis - drug therapy (61) 61
ciprofloxacin (60) 60
particle size (60) 60
tobramycin - therapeutic use (60) 60
tobramycin - analysis (59) 59
middle aged (58) 58
drug resistance (57) 57
vancomycin (56) 56
rats (55) 55
anti-bacterial agents - blood (53) 53
article (52) 52
chemistry (52) 52
dose-response relationship, drug (52) 52
escherichia-coli (52) 52
kinetics (52) 52
anti-bacterial agents - metabolism (51) 51
biofilm (51) 51
child (51) 51
gentamicins - pharmacology (51) 51
chemistry, pharmaceutical (49) 49
aminoglycoside (47) 47
antimicrobial agents (47) 47
materials science, biomaterials (47) 47
research article (47) 47
aerosols (46) 46
health aspects (45) 45
nanoparticles (44) 44
pathogens (44) 44
serum (44) 44
therapy (44) 44
binding (43) 43
biochemical research methods (42) 42
bone cements - chemistry (42) 42
kanamycin (42) 42
inhalation (41) 41
treatment outcome (41) 41
bacterial biofilms (40) 40
cystic fibrosis - complications (40) 40
cystic fibrosis - microbiology (40) 40
drug stability (40) 40
anti-bacterial agents - analysis (39) 39
inhaled tobramycin (39) 39
pseudomonas aeruginosa - physiology (39) 39
aged (38) 38
biochemical phenomena, metabolism, and nutrition (38) 38
drug therapy (38) 38
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1104) 1104
Japanese (10) 10
Chinese (8) 8
French (5) 5
German (3) 3
Russian (3) 3
Italian (2) 2
Czech (1) 1
Hungarian (1) 1
Norwegian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 01/2015, Volume 198, pp. 55 - 61
Inhaled antibiotics, such as tobramycin, for the treatment of Pseudomonas aeruginosa pulmonary infections are associated with the increase in life expectancy... 
Pseudomonas aeruginosa | Alginate | DNase | Tobramycin | Nanoparticle | Cystic fibrosis sputum | CHITOSAN/ALGINATE NANOPARTICLES | VIVO | DRUG-DELIVERY | SPUTUM | LUNG INFECTION | CHEMISTRY, MULTIDISCIPLINARY | BACTERIAL BIOFILMS | DEXTRAN SULFATE | IN-VITRO CHARACTERIZATION | GALLERIA-MELLONELLA | OCULAR DELIVERY | PHARMACOLOGY & PHARMACY | Recombinant Proteins - therapeutic use | Nanoparticles - chemistry | Humans | Pseudomonas aeruginosa - growth & development | Tobramycin - pharmacology | Deoxyribonuclease I - therapeutic use | Tobramycin - administration & dosage | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Deoxyribonuclease I - chemistry | Deoxyribonuclease I - pharmacology | Nanoparticles - therapeutic use | Anti-Bacterial Agents - chemistry | Adult | Tobramycin - chemistry | Glucuronic Acid - chemistry | Tobramycin - therapeutic use | Pseudomonas Infections - drug therapy | Recombinant Proteins - chemistry | Treatment Outcome | DNA - metabolism | Hexuronic Acids - chemistry | Pseudomonas aeruginosa - drug effects | Recombinant Proteins - pharmacology | Deoxyribonuclease I - administration & dosage | Chemistry, Pharmaceutical | Recombinant Proteins - administration & dosage | Sputum - metabolism | Chitosan - chemistry | Alginates - chemistry | Anti-Bacterial Agents - pharmacology | Nanoparticles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Cystic Fibrosis - drug therapy | Dornase alfa | Analysis | Cystic fibrosis | Polymers | Health aspects | Index Medicus
Journal Article
Analytica Chimica Acta, ISSN 0003-2670, 01/2019, Volume 1047, pp. 150 - 162
We reported a novel bimetallic cerium/copper-based metal organic framework (Ce/Cu-MOF) and its derivatives pyrolyzed at different temperatures, followed by... 
CeO2/CuOx | Bimetallic cerium/copper-based metal organic framework | Electrochemical aptasensor | Mesoporous carbon | Trace detection of tobramycin | CeO | CuO | AMPLIFIED DETECTION | CHEMISTRY, ANALYTICAL | ANTIBIOTICS DETECTION | MOF | LASER-INDUCED FLUORESCENCE | APTAMER | SENSITIVE DETECTION | AMINOGLYCOSIDE | DNA | CATALYTIC-ACTIVITY | Milk - chemistry | Limit of Detection | Reproducibility of Results | Nanocomposites - chemistry | Cerium - chemistry | Dielectric Spectroscopy - methods | Food Contamination - analysis | Humans | Oxides - chemistry | Aptamers, Nucleotide - chemistry | Tobramycin - blood | Metal-Organic Frameworks - chemistry | Carbon - chemistry | Animals | Copper - chemistry | Metal-Organic Frameworks - chemical synthesis | Biosensing Techniques - methods | Electrochemical Techniques - methods | Immobilized Nucleic Acids - chemistry | Porosity | Safety and security measures | Cerium | Tobramycin | Sensors | Copper oxide | Cuprite | Electric properties | Milk | Food | Chemical sensors | Metals | Oxides | Selectivity | High temperature | Metal oxides | Copper | Product safety | Cerium oxides | Open channels | Carbon | Organic chemistry | Bimetals | Nanocomposites | Antibiotics | Reproducibility | Aptamers | Electrochemistry | Food safety | Synergistic effect | Biosensors | Metal-organic frameworks | Copper oxides | Breast milk
Journal Article
Proteins: Structure, Function, and Bioinformatics, ISSN 0887-3585, 07/2017, Volume 85, Issue 7, pp. 1258 - 1265
ABSTRACT Kinetic, thermodynamic, and structural properties of the aminoglycoside N3‐acetyltransferase‐VIa (AAC‐VIa) are determined. Among the aminoglycoside... 
protein‐protein interactions | solution structure | analytical ultracentrifugation | isothermal titration calorimetry | antibiotic resistance | ligand‐protein interactions | ligand-protein interactions | protein-protein interactions | LIGAND-BINDING | ANTIBIOTIC-RESISTANCE ENZYME | BIOCHEMISTRY & MOLECULAR BIOLOGY | COENZYME-A | REARRANGEMENT | PROTEIN DYNAMICS | NMR | BIOPHYSICS | SOLVENT REORGANIZATION | PHOSPHOTRANSFERASE(3')-IIIA | SELECTION | Protons | Acetyltransferases - metabolism | Enterobacter cloacae - enzymology | Tobramycin - metabolism | Bacterial Proteins - chemistry | Deuterium Oxide - chemistry | Substrate Specificity | Acetyltransferases - genetics | Enterobacter cloacae - chemistry | Sisomicin - chemistry | Thermodynamics | Gentamicins - metabolism | Anti-Bacterial Agents - chemistry | Cloning, Molecular | Escherichia coli - metabolism | Water - chemistry | Protein Interaction Domains and Motifs | Tobramycin - chemistry | Binding Sites | Gentamicins - chemistry | Recombinant Proteins - metabolism | Gene Expression | Bacterial Proteins - genetics | Models, Molecular | Recombinant Proteins - chemistry | Anti-Bacterial Agents - metabolism | Recombinant Proteins - genetics | Sisomicin - metabolism | Acetyltransferases - chemistry | Amino Acid Motifs | Kanamycin - metabolism | Escherichia coli - genetics | Protein Binding | Bacterial Proteins - metabolism | Kanamycin - chemistry | Ligands | Structural Homology, Protein | Kinetics | Enzymes | Protein-protein interactions | Promiscuity | Carbohydrates | Solvents | Sisomicin | Aminoglycosides | Ultracentrifugation | Substrates | Proteins | Specific heat | Protonation | Acetyltransferase | Protein interaction
Journal Article
1983, Pharmacochemistry library, ISBN 0444996788, Volume 5, 590
Book
Journal Article
Journal Article
Drug Development and Industrial Pharmacy, ISSN 0363-9045, 09/2016, Volume 42, Issue 9, pp. 1406 - 1423
Journal Article
Journal of Natural Products, ISSN 0163-3864, 09/2016, Volume 79, Issue 9, pp. 2413 - 2417
Journal Article
Journal Article
ChemBioChem, ISSN 1439-4227, 11/2013, Volume 14, Issue 16, pp. 2127 - 2135
Journal Article
The Journal of Organic Chemistry, ISSN 0022-3263, 03/2007, Volume 72, Issue 6, pp. 1962 - 1979
The aminoglycoside antibiotic neomycin B has been converted into several novel building blocks that can be used for the specific modification of three of the... 
ANTHRAX LETHAL FACTOR | IN-VITRO | TOBRAMYCIN ANALOGS | INHIBITION | DIISOPROPYL AZODICARBOXYLATE | CYCLIC PHOSPHORANES | DRUG DISCOVERY | ESTERIFICATION REACTION | CHEMISTRY, ORGANIC | TERMINAL ALKYNES | 16S RIBOSOMAL-RNA | Epoxy Compounds | Aziridines